ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank29
3Y CAGR-48.9%
5Y CAGR-1.9%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

3Y CAGR
-48.9%/yr
vs +16.1%/yr prior
5Y CAGR
-1.9%/yr
Recent deceleration
Acceleration
-65.0pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
20254.39%
2024161.90%
2023187.55%
202232.88%
202127.97%
20204.82%
201917.71%
201818.12%
201765.97%
2016-6696.92%